Device Trial Radar · NCT05964907
Optimizing Phototesting and Investigating Photobiology of Visible Light
Last checked: Nov 19, 2026Latest source record: May 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
14
Planned (sponsor's estimate)
Start
Oct 6, 2021
Primary completion
Dec 30, 2026
Study completion Dec 30, 2026
Sponsor
- Lead sponsor
- Henry Ford Health SystemAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jul 28, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Specific Aim 1: To determine the impact of spectral composition of the VL+UVA1 source on the associated biologic effects. Specific Aim 2: To investigate differential responses of subjects with different skin phototypes to VL+UVA1, including immediate and delayed erythema and pigmentation, and photodamage.
Conditions
- Healthy
Interventions
Light Source B: Visible Light solar simulator (VL + UVA1)Device
Patients will be radiated with light source B (Visible light solar simulator)
Light Source A: Visible Light solar simulator closer match to sunlight (VL +UVA1)Device
Patients will be radiated with light source A (Visible light solar simulator closer match to sunlight)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Erythema assessment for all 14 participants.Time frame: Visit 1 (Day 0)
- Erythema assessment for all participantsTime frame: Visit 2 (Day 1)
- Erythema assessmentTime frame: Visit 3 (Day 7)
13 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Henry Ford Medical Center
Detroit, Michigan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.